A study of subcutaneous Cyt 99 007 (interleukin-7) in conjunction with peptide immunization [melanoma vaccine] in patients with metastatic melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-7; Melanoma vaccine
- Indications Malignant melanoma
- Focus Adverse reactions
- 30 Apr 2015 Biomarkers information updated
- 26 Apr 2007 Status change
- 08 Nov 2005 New trial record.